News

The products help to prevent the transmission of blood-borne diseases such as HIV and hepatitis C via needlestick injuries, aerosol dispersal and syringe reuse. Primary target markets of

By acquiring the Lab Systems division of Dynacon, a privately held corporation based in Ontario, Canada, BD adds product platforms in preanalytical microbiology automation. The product platforms include

The acquisition is expected to allow the integration of Medpace’s therapeutic expertise and global reach with the device expertise of Symbios to offer clinical trial management solutions to

SAFC said that the new facility complements its existing 63,000 sq ft HPAPI site in Madison and houses commercial scale reactors capable of producing HPAPI batch sizes up

Jantibody Therapeutics was created by Boston BioCom to commercialise a new class of immunologically-enhanced monoclonal antibodies (mAbs) that utilise heat shock protein 70 (HSP 70) for initial applications

BioAlliance Pharma is expected to receive up to EUR48.5m from Therabel, of which EUR6.5m as upfront payments including EUR4.5m at signature and two annual payments of EUR1m each

Purdue Pharma said that the drug is made to slowly release the potent opioid oxycodone to treat patients who require a continuous, around-the-clock opioid analgesic for management of

Intensive Nutrition claimed that NutriYummies are packed with nutrients essential to the physical and mental development of children ages 2-12, including Vitamin D, B Complex Vitamins, Calcium, Magnesium

The study showed that DepoVax platform promotes antigen specific immune responses, however, unlike the control vaccine, the DepoVax formulation does not induce problematic immune regulatory responses. DPX-0907 is